Lee's Pharmaceutical Holdings Limited (0950.HK)
HKD 1.3
(0.0%)
HKD 1.3
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.89 Billion HKD | 3.91% |
| 2022 | 2.78 Billion HKD | -23.51% |
| 2021 | 3.63 Billion HKD | 11.8% |
| 2020 | 3.25 Billion HKD | -10.64% |
| 2019 | 3.64 Billion HKD | 21.08% |
| 2018 | 3 Billion HKD | 29.34% |
| 2017 | 2.32 Billion HKD | 12.76% |
| 2016 | 2.06 Billion HKD | 11.36% |
| 2015 | 1.85 Billion HKD | 35.18% |
| 2014 | 1.36 Billion HKD | 17.48% |
| 2013 | 1.16 Billion HKD | 46.34% |
| 2012 | 796.53 Million HKD | 94.24% |
| 2011 | 410.07 Million HKD | 31.56% |
| 2010 | 311.71 Million HKD | 49.46% |
| 2009 | 208.56 Million HKD | 93.28% |
| 2008 | 107.91 Million HKD | 24.61% |
| 2007 | 86.59 Million HKD | 64.57% |
| 2006 | 52.62 Million HKD | 12.34% |
| 2005 | 46.84 Million HKD | -5.17% |
| 2004 | 49.39 Million HKD | 10.78% |
| 2003 | 44.58 Million HKD | -7.94% |
| 2002 | 48.43 Million HKD | 109.32% |
| 2001 | 23.13 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 FY | 2.89 Billion HKD | 3.91% |
| 2023 Q3 | 2.89 Billion HKD | -0.24% |
| 2023 Q4 | 2.89 Billion HKD | 0.0% |
| 2023 Q1 | 2.89 Billion HKD | 4.16% |
| 2023 Q2 | 2.89 Billion HKD | 0.0% |
| 2022 Q3 | - HKD | -100.0% |
| 2022 Q4 | 2.78 Billion HKD | 0.0% |
| 2022 FY | 2.78 Billion HKD | -23.51% |
| 2022 Q1 | - HKD | -100.0% |
| 2022 Q2 | 3.24 Billion HKD | 0.0% |
| 2021 FY | 3.63 Billion HKD | 11.8% |
| 2021 Q1 | - HKD | -100.0% |
| 2021 Q4 | 3.63 Billion HKD | 0.0% |
| 2021 Q2 | 4.61 Billion HKD | 0.0% |
| 2020 Q4 | 3.25 Billion HKD | 0.0% |
| 2020 Q1 | - HKD | -100.0% |
| 2020 Q2 | 3.5 Billion HKD | 0.0% |
| 2020 FY | 3.25 Billion HKD | -10.64% |
| 2019 Q1 | - HKD | -100.0% |
| 2019 FY | 3.64 Billion HKD | 21.08% |
| 2019 Q2 | 3.4 Billion HKD | 0.0% |
| 2019 Q4 | 3.64 Billion HKD | 0.0% |
| 2018 Q2 | 2.63 Billion HKD | 0.0% |
| 2018 FY | 3 Billion HKD | 29.34% |
| 2018 Q1 | - HKD | -100.0% |
| 2018 Q4 | 3 Billion HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 FY | 2.32 Billion HKD | 12.76% |
| 2017 Q4 | 2.32 Billion HKD | 0.0% |
| 2017 Q2 | 2.11 Billion HKD | 0.0% |
| 2016 FY | 2.06 Billion HKD | 11.36% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 Q2 | 1.95 Billion HKD | 0.0% |
| 2016 Q4 | 2.06 Billion HKD | 0.0% |
| 2015 FY | 1.85 Billion HKD | 35.18% |
| 2015 Q2 | 1.85 Billion HKD | 0.0% |
| 2015 Q4 | 1.85 Billion HKD | 0.0% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2014 Q4 | 1.36 Billion HKD | 0.0% |
| 2014 FY | 1.36 Billion HKD | 17.48% |
| 2014 Q2 | 1.21 Billion HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 FY | 1.16 Billion HKD | 46.34% |
| 2013 Q4 | 1.16 Billion HKD | 0.0% |
| 2013 Q2 | 882.79 Million HKD | 0.0% |
| 2012 FY | 796.53 Million HKD | 94.24% |
| 2012 Q2 | 661.19 Million HKD | 0.0% |
| 2012 Q4 | 796.53 Million HKD | 0.0% |
| 2011 FY | 410.07 Million HKD | 31.56% |
| 2011 Q2 | 340.55 Million HKD | 0.0% |
| 2011 Q4 | 410.07 Million HKD | 0.0% |
| 2010 Q2 | 216.56 Million HKD | 0.0% |
| 2010 FY | 311.71 Million HKD | 49.46% |
| 2009 FY | 208.56 Million HKD | 93.28% |
| 2008 FY | 107.91 Million HKD | 24.61% |
| 2007 FY | 86.59 Million HKD | 64.57% |
| 2006 FY | 52.62 Million HKD | 12.34% |
| 2005 FY | 46.84 Million HKD | -5.17% |
| 2004 FY | 49.39 Million HKD | 10.78% |
| 2003 FY | 44.58 Million HKD | -7.94% |
| 2002 FY | 48.43 Million HKD | 109.32% |
| 2001 FY | 23.13 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -218.543% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 87.161% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -124.572% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | -37.972% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -504.594% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | -2.232% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | -67.348% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -242.511% |
| SSY Group Limited | 11.96 Billion HKD | 75.843% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -108.157% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 17.098% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 98.936% |